Elsa Maître (Elsa Maitre)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Acute Myeloid Leukemia

Prognostic Factors

Diffuse Large B Cell Lymphoma

Top Venues

American journal of hematology

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xavier Troussard, Elsa Maître, Jérôme Paillassa
Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies. American journal of hematology 99 (4) (2024)
Fabien Claves, Sylvain Carras, Barbara Burroni, Elsa Maître, Jean Boutonnat, Xavier Troussard, Lysiane Molina
Atypical meningeal localization of classical hairy cell leukemia with an impressive response to rituximab and cladribine association. A case report and literature review. EJHaem 5 (1) (2024)
Xavier Troussard, Elsa Maître, Jérôme Paillassa
Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies. American journal of hematology 99 (4) (2024)
Xavier Troussard, Elsa Maître, Jérôme Paillassa
Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies. American journal of hematology 99 (4) (2024)
Xavier Troussard, Elsa Maître, Jérôme Paillassa
Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies. American journal of hematology (2024)
Jérôme Paillassa, Elsa Maître, Nadia Belarbi Boudjerra, Abdallah Madani, Raihane Benlakhal, Thomas Matthes, Eric Van Den Neste, Laura Cailly, Luca Inchiappa, Mohammed Amine Bekadja, Cécile Tomowiak, Xavier Troussard
Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group. Cancers 16 (12) (2024)
Fabien Claves, Sylvain Carras, Barbara Burroni, Elsa Maître, Jean Boutonnat, Xavier Troussard, Lysiane Molina
Atypical meningeal localization of classical hairy cell leukemia with an impressive response to rituximab and cladribine association. A case report and literature review. EJHaem 5 (1) (2024)
Jérôme Paillassa, Elsa Maître, Nadia Belarbi Boudjerra, Abdallah Madani, Raihane Benlakhal, Thomas Matthes, Eric Van Den Neste, Laura Cailly, Luca Inchiappa, Mohammed Amine Bekadja, Cécile Tomowiak, Xavier Troussard
Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group. Cancers 16 (12) (2024)
Xavier Troussard, Elsa Maître
Untangling hairy cell leukaemia (HCL) variant and other HCL-like disorders: Diagnosis and treatment. Journal of cellular and molecular medicine (2023)
Elsa Maître, Margaret Macro, Xavier Troussard
Hairy cell leukaemia with unusual BRAF mutations. Journal of cellular and molecular medicine (2023)
Elsa Maître, Cécile Tomowiak, Benjamin Lebecque, Fontanet Bijou, Khaled Benabed, Dina Naguib, Pauline Kerneves, Edouard Cornet, Pierre-Julien Viailly, Jeffrey Arsham, Brigitte Sola, Fabrice Jardin, Xavier Troussard
Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients. Cancers 14 (8) (2022)
Elsa Maître, Edouard Cornet, Véronique Salaün, Pauline Kerneves, Stéphane Chèze, Yohan Repesse, Gandhi Damaj, Xavier Troussard
Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders. Cancers 14 (4) (2022)
Alessandro Broccoli, Lisa Argnani, Matthew Cross, Agnieszka Janus, Elsa Maître, Xavier Troussard, Tadeusz Robak, Claire Dearden, Monica Else, Daniel Catovsky, Pier Luigi Luigi Zinzani
A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia. Blood advances 6 (14) (2022)
Xavier Troussard, Elsa Maître, Edouard Cornet
Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment. American journal of hematology (2021)
Mélody Caillot, Florence Zylbersztejn, Elsa Maître, Jérôme Bourgeais, Olivier Herault, Brigitte Sola
ROS Overproduction Sensitises Myeloma Cells to Bortezomib-Induced Apoptosis and Alleviates Tumour Microenvironment-Mediated Cell Resistance. Cells 9 (11) (2020)